UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Zero Based Budgeting for startups helps allocate scarce resources efficiently. Learn how to map expenses to revenue goals and sustain early growth.
21,083 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...
Tesla’s stock price problem remains in focus as shares hover in a tight range amid mixed demand data and bets on AI v...
As market chatter heats up in 2026, investors are watching whether GE Vernova, MercadoLibre, or NVR will join the gro...
A $1.8 billion slush fund to reimburse Trump allies for legal costs sparks a GOP backlash. The move raises red flags ...
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
AI-driven memory demand pushed Micron stock to an all-time high, signaling how the data center boom and chip scarcity...
Hut 8 is shifting from pure mining to an infrastructure landlord role, using long-term leases, project debt, and BTC ...
OP Labs reports a turning point for crypto monetization as exchange-owned stack chains made a near-$500 million oncha...
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...